Ticker Details
NewAmsterdam Pharma Company
IPO Date:	February 9, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.14B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 2.78%
Avg Daily Range (30 D):	$1.04 | 3.06%
Avg Daily Range (90 D):	$0.88 | 2.68%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	1.22M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	1,317
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$1.82M
Avg Institutional Trade (90 D):	$1.69M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.76M
Avg Closing Trade (30 D):	$2.42M
Avg Closing Trade (90 D):	$2.16M
Avg Closing Volume:	63.23K

News

May 1, 2026 @ 8:57 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Na

Apr 2, 2026 @ 9:43 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Newamsterdam Pharma Company N.V.

Feb 4, 2026 @ 1:00 PM NewAmsterdam Pharma to Present at the Guggenheim E... Source: Newamsterdam Pharma Company N.V.

Aug 7, 2025 @ 12:21 AM NewAmsterdam (NAMS) Q2 Revenue Jumps 49% Source: Jesterai

Jun 9, 2025 @ 11:00 AM NewAmsterdam Pharma Announces Positive Topline Alz... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.79	$-.4	$-.63
Diluted EPS	$-1.79	$-.4	$-.63
Revenue	$22.57M	$3.04M	$.03M
Gross Profit
Net Income / Loss	$-212.73M	$-48.44M	$-74.92M
Operating Income / Loss	$-215.18M	$-58.42M	$-65.98M
Cost of Revenue
Net Cash Flow	$-297.13M	$-31.05M	$-48.33M
PE Ratio